idursulfase

Ukraine

Drugs containing this active substance

ELAPRAZA

The drug is intended for the long-term treatment of people with Hunter syndrome (mucopolysaccharidosis type II).

Form: concentrate for infusion solution

Active substance	Dosage
idursulfase	2 mg/ml

Manufacturer: Shire Pharmaceuticals Ireland Limited (responsible for batch release) / Takeda Pharmaceuticals International AG Ireland Branch (responsible for batch release)